茵栀黄颗粒联合双歧杆菌三联活菌胶囊治疗新生儿高胆红素血症疗效观察

Observation of the efficacy of yinzhihuang particles combined with bifid triple viable capsule in the treatment of neonatal with hyperbilirubinemia

目的 :观察茵栀黄颗粒联合双歧杆菌三联活菌胶囊治疗新生儿高胆红素血症的疗效。方法 :将高胆红素血症患儿依家长意愿分为两组,观察组予茵栀黄颗粒联合双歧杆菌三联活菌胶囊口服,对照组予清肝利胆口服液口服,连服5 d,观察两组患儿经皮胆红素的变化。结果 :观察组与对照组治疗5 d后,黄疸均较前减轻,但观察组疗效更显著,不良反应较对照组少。结论:茵栀黄颗粒联合双歧杆菌三联活菌胶囊治疗新生儿高胆红素血症疗效确切,不良反应较少。

Objective： To investigate the clinical efficacy of yinzhihuang particles combined with bifid triple viable capsule in the treatment of neonatal with hyperbilirubinemia. Methods： Newborn infants with hyperbilirubinemia were divided into an observation group and a control group based on the request of parents. Yinzhihuang particles combined with bifid triple viable capsule were given in the observation group while only Qinggan-Lidan decoction in the control group for 5 days. The efficacy and the changes of transcutaneous bilirubin measurement were observed and compared between the two groups. Results： The jaundice was all regressed in the two groups but the efficacy was more significant in the observation group than in the control group（P〈0.05）, and the incidence of adverse reactions was less in the observation group than in the control group. Conclusion： The efficacy of Yinzhihuang particles combined with bifid triple viable capsule in the treatment of neonatal with hyperbilirubinemia is more effective with less adverse reactions.